Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations (Q73544347)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1999

Language	Label	Description	Also known as
English	Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations	scientific article published on 01 December 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

based on heuristic

inferred from title

author name string

M J Rosenberg

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Meyers

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

V Roy

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

60

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

321-329

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Epidemiology of oral contraceptives and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Modern oral contraceptives and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Compliance and oral contraceptives: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Cycle control with oral contraceptives: A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Oral contraceptives and cycle control: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Triphasic Randomized Clinical Trial: comparative frequency of intermenstrual bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Smoking and cycle control among oral contraceptive users

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

The antiestrogenic effect of cigarette smoking in women

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle contr

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Maximum utilization of the life table method in analyzing survival

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Statistical comparison of Pearl rates

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900109-2

7 January 2021

Identifiers

10.1016/S0010-7824(99)00109-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715366%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73544347&oldid=1946724968"